Federated Hermes
MDGL icon

Federated Hermes’s Madrigal Pharmaceuticals MDGL Stock Holding History

Federated Hermes’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.01M Sell
14,914
-1,989
-12% -$1.02M 0.01% 751
2026
Q1 		$8.85M Buy
16,903
+578
+4% +$276K 0.01% 674
2025
Q4 		$9.51M Buy
16,325
+12,440
+320% +$6.35M 0.02% 630
2025
Q3 		$1.78M Buy
+3,885
New +$1.45M ﹤0.01% 964
2025
Q2 		– Sell
-58,025
Closed -$19.2M – 2138
2025
Q1 		$19.2M Buy
+58,025
New +$19.1M 0.04% 411
2022
Q4 		– Sell
-240,000
Closed -$15.6M – 2231
2022
Q3 		$15.6M Hold
240,000
– – 0.05% 436
2022
Q2 		$17.2M Sell
240,000
-102,597
-30% -$7.54M 0.05% 427
2022
Q1 		$33.6M Buy
+342,597
New +$28.9M 0.08% 319
2021
Q4 		– Sell
-3,303
Closed -$264K – 2259
2021
Q3 		$264K Sell
3,303
-2,599
-44% -$224K ﹤0.01% 1619
2021
Q2 		$575K Buy
+5,902
New +$699K ﹤0.01% 1478
2018
Q4 		– Sell
-18
Closed -$4K – 2261
2018
Q3 		$4K Sell
18
-4,525
-100% -$1.14M ﹤0.01% 2086
2018
Q2 		$1.27M Buy
4,543
+4,523
+22,615% +$794K ﹤0.01% 1205
2018
Q1 		$2K Sell
20
-266
-93% -$32.8K ﹤0.01% 2061
2017
Q4 		$26K Buy
286
+123
+75% +$7.03K ﹤0.01% 1733
2017
Q3 		$7K Buy
+163
New +$3.05K ﹤0.01% 1910

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes's MDGL Position: Q2 2026 in Review

Federated Hermes reduced its Madrigal Pharmaceuticals (MDGL) stake by 12% in Q2 2026, selling an estimated $1.02M and leaving 14,914 shares worth $8.01M. The position accounts for 0.01% of the portfolio, ranked #751.

Federated Hermes first reported a position in MDGL in Q3 2017 and has held it in 15 quarters since. The position peaked at $33.6M in Q1 2022. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Federated Hermes held 14,914 shares of Madrigal Pharmaceuticals worth $8.01M as of Q2 2026.
  • Federated Hermes sold 1,989 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.02M.
  • Madrigal Pharmaceuticals made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #751 holding.
  • Federated Hermes first reported a position in Madrigal Pharmaceuticals in Q3 2017 and has held it in 15 quarters since.
  • Federated Hermes's Madrigal Pharmaceuticals position peaked at $33.6M in Q1 2022.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.